Related references
Note: Only part of the references are listed.Cardiac involvement in primary Sjogren's syndrome
Li Qin et al.
RHEUMATOLOGY INTERNATIONAL (2022)
Dose-response association between serum uric acid levels and incident hypertension: a systematic review and meta-analysis of 17 prospective cohort studies of 32 thousand participants
Leilei Liu et al.
ACTA CARDIOLOGICA (2021)
Association of serum uric acid with mortality and cardiovascular outcomes in patients with hypertension: a meta-analysis
Yong Yang et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)
Diagnosis and management of hypertension in adults: NICE guideline update 2019
N. R. Jones et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2020)
Cardiovascular Morbidity and Mortality in Primary Sjogren's Syndrome: A Systematic Review and Meta-Analysis
Aurelie Beltai et al.
ARTHRITIS CARE & RESEARCH (2020)
Uric Acid and Hypertension: An Update With Recommendations
Laura G. Sanchez-Lozada et al.
AMERICAN JOURNAL OF HYPERTENSION (2020)
Quality of life and influencing factors of patients with rheumatoid arthritis in Northeast China
Bingqing Bai et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2020)
Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases
Elena Bartoloni et al.
NATURE REVIEWS CARDIOLOGY (2018)
Comorbidity of gout and rheumatoid arthritis in a large population database
Rona Merdler-Rabinowicz et al.
CLINICAL RHEUMATOLOGY (2017)
Antioxidant status of serum bilirubin and uric acid in patients with polymyositis and dermatomyositis
Zhibo Chen et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2017)
Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases Five-Year Japanese Cohort Study
Masanari Kuwabara et al.
HYPERTENSION (2017)
Role of Inflammatory Diseases in Hypertension
E. Bartoloni et al.
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2017)
Uric acid is independent cardiovascular risk factor, as manifested by increased carotid intima-media thickness in rheumatoid arthritis patients
Suad Hannawi et al.
CLINICAL RHEUMATOLOGY (2017)
Systemic activity and mortality in primary Sjogren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients
P. Brito-Zeron et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Hiperuricemia no lúpus eritematoso sistêmico: está associada a manifestações neuropsiquiátricas da doença?
Mahdi Sheikh et al.
Revista Brasileira De Reumatologia (2015)
High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension
Ki-Jo Kim et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2015)
EULAR Sjogren's syndrome disease activity index (ESSDAI): a user guide
Raphaele Seror et al.
RMD OPEN (2015)
Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients
Chiara Baldini et al.
RHEUMATOLOGY (2014)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2013)
Uric Acid and the Origins of Hypertension
Daniel I. Feig et al.
JOURNAL OF PEDIATRICS (2013)
Serum uric acid is independently associated with hypertension in patients with rheumatoid arthritis
V. F. Panoulas et al.
JOURNAL OF HUMAN HYPERTENSION (2008)
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States
Charles G. Helmick et al.
ARTHRITIS AND RHEUMATISM (2008)
Gout-associated uric acid crystals activate the NALP3 inflammasome
F Martinon et al.
NATURE (2006)
Uric acid-induced C-reactive protein expression: Implication on cell proliferation and nitric oxide production of human vascular cells
DH Kang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
RJ Johnson et al.
HYPERTENSION (2003)
Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group
C Vitali et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Share Paper
